• 
  Alexandre Belot, Gillian Rice, Sulliman Ommar Omarjee, Quentin Rouchon, Eve Smith, et al.. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2020, 2 (2), pp.e99-e109. ⟨10.1016/S2665-9913(19)30142-0⟩. ⟨hal-02867795⟩
• 
  Denis Vincent, Faidra Parsopoulou, Ludovic Martin, Christine Gaboriaud, Jacques Demongeot, et al.. Hereditary angioedema with normal C1 Inhibitor associated with Carboxypeptidase N deficiency. Journal of Allergy and Clinical Immunology: Global, 2024, ⟨10.1016/j.jacig.2024.100223⟩. ⟨hal-04461816⟩
• 
  Julien Lupo, Anne-Sophie Wielandts, Marlyse Buisson, Mohammed Habib, Marwan Hamoudi, et al.. High predictive value of the soluble ZEBRA antigen (Epstein-Barr virus trans-activator Zta) in transplant patients with PTLD. Pathogens, 2022, 11 (8), pp.928. ⟨10.3390/pathogens11080928⟩. ⟨hal-04420033⟩
• 
  Vincent Jean-Pierre, Julien Lupo, Marlyse Buisson, Patrice Morand, Raphaële Germi. Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine. Frontiers in Microbiology, 2021, 12, pp.701611. ⟨10.3389/fmicb.2021.701611⟩. ⟨hal-04419945⟩
• 
  Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, Grégory Quéromès, Nicolas Guibert, et al.. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Scientific Reports, 2021, 11 (1), pp.14977. ⟨10.1038/s41598-021-93828-y⟩. ⟨hal-04411150⟩

60

75